Yogaros 20 Tablet contains Rosuvastatin 20mg, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to decreased cholesterol production in the liver and increased clearance of LDL particles from the bloodstream. Yogaros 20 is prescribed as an adjunct to diet, lifestyle modifications, and other non-pharmacological interventions to reduce the risk of cardiovascular events such as myocardial infarction, stroke, and atherosclerosis in patients with established cardiovascular disease or those at high risk. The tablet should be administered once daily, with or without food, preferably at the same time each day. Caution is advised in patients with hepatic or renal impairment, and periodic monitoring of liver enzymes and lipid profiles is recommended during therapy. Potential adverse effects include myopathy, elevated liver enzymes, and gastrointestinal disturbances. Yogaros 20 should be used under medical supervision with appropriate monitoring to ensure safety and efficacy.